The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence

Prostate cancer (PCa) induced death is the predominant cause of cancer-related death among men in 48 countries. After radical treatment, biochemical recurrence has become an important factor for prognosis. The early detection and diagnosis of recurrent lesions are very helpful in guiding treatment a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jie, Tang, Xiaoxia, Pu, Yongzhu, Yang, Yong, Yang, Conghui, Yang, Fake, Tian, Yadong, Li, Jindan, Sun, Hua, Zhao, Sheng, Chen, Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197252/
https://www.ncbi.nlm.nih.gov/pubmed/35712249
http://dx.doi.org/10.3389/fendo.2022.897513
Descripción
Sumario:Prostate cancer (PCa) induced death is the predominant cause of cancer-related death among men in 48 countries. After radical treatment, biochemical recurrence has become an important factor for prognosis. The early detection and diagnosis of recurrent lesions are very helpful in guiding treatment and improving the prognosis. PET/CT is a promising method for early detection of lesions in patients with biochemical recurrence of prostate cancer. This article reviews the progress of the research on PET/CT in the PCa biochemical recurrence and aims to introduce new technologies and provide more direction for future research.

Ejemplares similares